Increasing pressure faced by pharmaceutical companies to make their supply chain more efficient, cost effective, focused and more agile has made the industry increasingly competitive in the recent years. With the mandate for serialization, strict quality regulations and increasing importance of patient centricity for pharma companies to follow, it is essential to navigate from complex supply chain ecosystem to simpler processes. Now with the additional roadblocks and problems due to the pandemic (global outbreak), the pharma supply chain is faring. Major problem being the impact of COVID-19 on two of the largest global producers of active pharmaceutical ingredients (APIs) and generics: China and India.
MarketsandMarkets World Pharma Logistics and Supply Chain Digital Conference will hold use case discussions on how to build a supply chain which is more agile, that can operate faster and react to such unpredictable and predictable changes in the market. Expert speakers from top pharma companies will share their real-life use case on crisis management during the pandemic on a global basis.How adapting to newer technologies and solutions at various stages of the supply chain can reduce the impact faced due to this pandemic and how practical it is to adapt to the available solutions in the market. The digital event will witness an overwhelming participation of leading supply chain and logistics decision makers discussing on how collaboration can be a key in solving the issues faced at various stages of pharma logistics.